Alemtuzumab provides greater reductions in serum NfL than interferon beta-1aMay 28, 2019Multiple Sclerosis
Fingolimod reduced disease activity more than glatiramer acetate in RRMS: ASSESS study resultsMay 14, 2019Multiple Sclerosis
Researchers examine vitamin D, skin pigmentation, and outcomes of pediatric MSMay 7, 2019Multiple Sclerosis
Criterion based on the central vein sign distinguishes between MS and mimicsMay 7, 2019Multiple Sclerosis
Cerebellar volume may predict disability in patients with relapsing-remitting MSApril 1, 2019Multiple Sclerosis
Imaging mass cytometry sheds light on inflammation, demyelination in MSMarch 28, 2019Multiple Sclerosis
MS researchers aim to build MRI diagnostic portfolio beyond the central vein signMarch 27, 2019Multiple Sclerosis
